Hidehiko Fukahori
Tsukuba, 3058585, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications
Lit-LAMP-DNA-vaccine for shrimp allergy prevents anaphylactic symptoms in a murine model.
Journal: International immunopharmacology
Published: August 29, 2022
Development of a novel Poly (I:C)-induced murine model with accelerated lupus nephritis and examination of the therapeutic effects of mycophenolate mofetil and a cathepsin S inhibitor.
Journal: European journal of pharmacology
Published: August 12, 2022
Impacts of dosing and drug withdrawal period on tacrolimus-based triple therapy in a non-human primate renal transplantation model.
Journal: Transplant immunology
Published: April 26, 2022
Potential benefit of the cathepsin S inhibitor, ASP1617, as a treatment for systemic lupus erythematosus.
Journal: European journal of pharmacology
Published: October 28, 2021
Effects of AS2819899, a novel selective PI3Kδ inhibitor, in a NZB/W F1 mouse lupus-like nephritis model.
Journal: International immunopharmacology
Published: January 24, 2020
In vitro pharmacological effects of peficitinib on lymphocyte activation: a potential treatment for systemic sclerosis with JAK inhibitors.
Journal: Rheumatology (Oxford, England)
Published: July 08, 2019
The PI3Kδ selective inhibitor AS2541019 suppresses donor-specific antibody production in rat cardiac and non-human primate renal allotransplant models.
Journal: International immunopharmacology
Published: March 25, 2019
Optimization of 5,6,7,8-tetrahydropyrido[4,3-d]pyrimidines to generate a highly selective PI3Kδ inhibitor.
Journal: Bioorganic & medicinal chemistry
Published: January 09, 2019
Replacement of mycophenolate mofetil with a JAK inhibitor, AS2553627, in combination with low-dose tacrolimus, for renal allograft rejection in non-human primates.
Journal: International immunopharmacology
Published: June 26, 2018
Effective suppression of donor specific antibody production by Cathepsin S inhibitors in a mouse transplantation model.
Journal: European journal of pharmacology
Published: June 22, 2018
Optimization and in vivo evaluation of pyrazolopyridines as a potent and selective PI3Kδ inhibitor.
Journal: Bioorganic & medicinal chemistry
Published: April 27, 2018
Discovery and biological evaluation of novel pyrazolopyridine derivatives as potent and orally available PI3Kδ inhibitors.
Journal: Bioorganic & medicinal chemistry
Published: March 01, 2018
Last Updated: 09/26/2026